To mark the 40th Foundation Day of Department of Biotechnology, Union Minister Dr Jitendra Singh launches “SUJVIKA” AI driven Biotech Product Data Portal, developed in collaboration with Industry partners ABLE

1. At a Glance

• SUJVIKA is an AI-driven Biotech Product Data Portal launched by the Department of Biotechnology (DBT) with industry body ABLE to track biotech import data and guide indigenisation/R&D [S1].
• Launched on 24 February 2026 to mark DBT's 40th Foundation Day by Union MoS (I/C) S&T Dr Jitendra Singh [S1].
• Anchors India's roadmap to a $1 trillion bioeconomy by 2047 and the BioE3 Policy for high-performance biomanufacturing [S1][S3].

2. Why in the News

• 24 Feb 2026: SUJVIKA portal launched at DBT's 40th Foundation Day; bioeconomy declared to have grown 16-fold in a decade to $165.7 billion [S1].
• Announcement of ₹2,000 crore RDI National Call to boost biotech enterprises and AI–biotech synergy [S1].

3. Background & Evolution

• DBT set up in 1986 under the Ministry of Science & Technology — completes 40 years in 2026 [S1].
• Association of Biotechnology Led Enterprises (ABLE) — industry partner co-developing SUJVIKA [S1].
• BioE3 Policy approved by Union Cabinet in August 2024; formally released by Dr Jitendra Singh [S2][S3].
• Bioeconomy trajectory: ~$10 bn (2014) → $165.75 bn (2024) [S4].

4. Core Static Facts

• Full form (BioE3): Biotechnology for Economy, Environment and Employment [S3].
• Parent ministry: Ministry of Science & Technology → Department of Biotechnology [S1].
• Industry partner for SUJVIKA: ABLE (Association of Biotechnology Led Enterprises) [S1].
• SUJVIKA function: Trade Statistics Digital Intelligence Platform — authenticated biotech import data (biochemicals, industrial enzymes etc.) for indigenisation, R&D prioritisation, PPP [S1].
• Bioeconomy 2024: $165.7 billion (16x in a decade) [S1][S4].
• Bioeconomy targets: $300 bn by 2030; $1 trillion by 2047 [S1][S2].
• Biotech startups since 2014: >11,000 [S1].
• RDI National Call: ₹2,000 crore for biotech enterprises [S1].
• BioE3 instruments: Biomanufacturing & Bio-AI hubs, Biofoundry; aligned with Net Zero and Mission LiFE [S3].

5. Multi-Dimensional Analysis

• Economic: Targets $1 trillion bioeconomy by 2047; SUJVIKA enables import substitution by mapping high-value/high-volume biotech imports [S1].
• Scientific/Technological: AI–biotech convergence; Bio-AI hubs, Biofoundries; supports precision bio-manufacturing of enzymes, vaccines, therapeutics [S3].
• Environmental: BioE3 aligned with Net Zero carbon economy and Mission LiFE; sustainable biomanufacturing reduces fossil-based inputs [S3].
• Administrative/Governance: PPP model (DBT + ABLE); evidence-based planning via authenticated trade data; states urged to set up BioE3 cells [S2].
• Strategic: Reduces dependency on biotech imports; positions India as global leader in next "industrial revolution" (bio-based) [S1][S2].

6. Recent Developments

• Aug 2024: Cabinet approves BioE3 Policy [S3].
• 2024: Bioeconomy crosses $165.75 bn [S4].
• 24 Feb 2026: DBT 40th Foundation Day — SUJVIKA launched; ₹2,000 cr RDI Call announced [S1].
• States asked to set up BioE3 cells for Bio-Vision Viksit Bharat 2047 [S2].

7. Prelims Hooks

• SUJVIKA = AI-driven Biotech Product Data Portal of DBT, launched 24 Feb 2026 [S1].
• Developed in collaboration with ABLE (industry body), not a foreign agency [S1].
• DBT established in 1986; completed 40 years in 2026 [S1].
• BioE3 Policy approved by Cabinet in 2024; expansion = Biotechnology for Economy, Environment & Employment [S3].
• Indian bioeconomy in 2024: $165.7 billion [S1][S4].
• Bioeconomy target: $300 bn by 2030; $1 trillion by 2047 [S1][S2].
• >11,000 biotech startups in India since 2014 [S1].
• RDI National Call corpus: ₹2,000 crore [S1].
• BioE3 envisages Biofoundry and Bio-AI hubs [S3].
• BioE3 aligned with Mission LiFE and Net Zero [S3].
• Implementing ministry: Ministry of Science & Technology (DBT) — not MoEFCC or DST [S1].
• SUJVIKA tracks biotech imports (industrial enzymes, biochemicals) for indigenisation [S1].

8. Mains Relevance

• GS-III: Science & Technology — indigenisation, biotech, AI applications; Economy — bioeconomy, manufacturing.
• GS-II: Government policies — BioE3, PPP in S&T.
• Question stems:
• "Critically examine how the BioE3 Policy and digital platforms like SUJVIKA can help India achieve a $1 trillion bioeconomy by 2047."
• "Discuss the role of AI–biotech convergence in sustainable biomanufacturing in India."
• "Evaluate the contribution of the Department of Biotechnology over four decades in shaping India's innovation ecosystem."

9. Related Topics to Study Next

• BioE3 Policy 2024 — parent policy framework.
• Biotech-KISAN, BIRAC — DBT flagship programmes.
• National Biopharma Mission — vaccines/diagnostics push.
• Anusandhan National Research Foundation (ANRF) — RDI funding architecture.
• Mission LiFE & Net Zero 2070 — sustainability anchors of BioE3.
• India AI Mission — AI synergy angle.
• Startup India — links to 11,000+ biotech startups.
• GM crops & GEAC — biotech regulation overlap.

10. Common Errors / Trap Areas

• SUJVIKA is under DBT (Min. of S&T), not MeitY or MoEFCC.
• ABLE is an Indian industry association, not a government body or foreign partner.
• BioE3 = Economy, Environment, Employment — not "Education" or "Energy".
• Bioeconomy figure $165.7 bn is for 2024, not 2026; target $300 bn is by 2030, $1 trillion by 2047.
• DBT founded 1986, not 1985 or 1984 (40 years marked in 2026).

11. Sources

• [S1] PIB — SUJVIKA launch / DBT 40th Foundation Day — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2232332 — (tier 1)
• [S2] PIB — BioE3 cells & Bio-Vision Viksit Bharat 2047 — https://pib.gov.in/PressReleaseIframePage.aspx?PRID=2100800 — (tier 1)
• [S3] PIB — Cabinet approves BioE3 Policy — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2048569 — (tier 1)
• [S4] PIB — Rise of India's Bioeconomy $10bn → $165.75bn — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2115882 — (tier 1)